Health Catalyst Inc (HCAT) Stock AnalysisHCATStock AnalysisHealth Catalyst Inc

Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements. It operates in the Technology sector (SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ET industry).

Health Catalyst Inc is not a good buy right now due to its declining financial performance and negative market sentiment. The current price is $1.59, which is significantly below the analyst price target of $1.80. Additionally, the stock has a low RSI of 33.129, indicating it is oversold, but this does not outweigh the risks of continued losses, as evidenced by a staggering net income loss of $111 million in Q1 2026. The main risk is the insider selling, which has increased by 869.22% over the last month, signaling a lack of confidence from those closest to the company.